Oxygen glucose deprivation switches the transport of tPA across the blood-brain barrier from an LRP-dependent to an increased LRP-independent process - PubMed (original) (raw)
Oxygen glucose deprivation switches the transport of tPA across the blood-brain barrier from an LRP-dependent to an increased LRP-independent process
Karim Benchenane et al. Stroke. 2005 May.
Abstract
Background and purpose: Despite uncontroversial benefit from its thrombolytic activity, the documented neurotoxic effect of tissue plasminogen activator (tPA) raises an important issue: the current emergency stroke treatment might not be optimum if exogenous tPA can enter the brain and thus add to the deleterious effects of endogenous tPA within the cerebral parenchyma. Here, we aimed at determining whether vascular tPA crosses the blood-brain barrier (BBB) during cerebral ischemia, and if so, by which mechanism.
Methods: First, BBB permeability was assessed in vivo by measuring Evans Blue extravasation following intravenous injection at 0 or 3 hours after middle cerebral artery electrocoagulation in mice. Second, the passage of vascular tPA was investigated in an in vitro model of BBB, subjected or not to oxygen and glucose deprivation (OGD).
Results: We first demonstrated that after focal permanent ischemia in mice, the BBB remains impermeable to Evans Blue in the early phase (relative to the therapeutic window of tPA), whereas at later time points massive Evans Blue extravasation occurs. Then, the passage of tPA during these 2 phases, was investigated in vitro and we show that in control conditions, tPA crosses the intact BBB by a low-density lipoprotein (LDL) receptor-related protein (LRP)-dependent transcytosis, whereas OGD leads to an exacerbation of tPA passage, which switches to a LRP-independent process.
Conclusions: We evidence 2 different mechanisms through which vascular tPA can reach the brain parenchyma, depending on the state of the BBB. As discussed, these data show the importance of taking the side effects of blood-derived tPA into account and offer a basis to improve the current thrombolytic strategy.
Similar articles
- Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein.
Yepes M, Sandkvist M, Moore EG, Bugge TH, Strickland DK, Lawrence DA. Yepes M, et al. J Clin Invest. 2003 Nov;112(10):1533-40. doi: 10.1172/JCI19212. J Clin Invest. 2003. PMID: 14617754 Free PMC article. - Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor-related protein-mediated transcytosis.
Benchenane K, Berezowski V, Ali C, Fernández-Monreal M, López-Atalaya JP, Brillault J, Chuquet J, Nouvelot A, MacKenzie ET, Bu G, Cecchelli R, Touzani O, Vivien D. Benchenane K, et al. Circulation. 2005 May 3;111(17):2241-9. doi: 10.1161/01.CIR.0000163542.48611.A2. Epub 2005 Apr 25. Circulation. 2005. PMID: 15851587 - Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein mediate cerebral ischemia-induced nuclear factor-kappaB pathway activation.
Zhang X, Polavarapu R, She H, Mao Z, Yepes M. Zhang X, et al. Am J Pathol. 2007 Oct;171(4):1281-90. doi: 10.2353/ajpath.2007.070472. Epub 2007 Aug 23. Am J Pathol. 2007. PMID: 17717150 Free PMC article. - tPA in the central nervous system: relations between tPA and cell surface LRPs.
Ortolano S, Spuch C. Ortolano S, et al. Recent Pat Endocr Metab Immune Drug Discov. 2013 Jan;7(1):65-76. Recent Pat Endocr Metab Immune Drug Discov. 2013. PMID: 23231415 Review. - Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator.
Jin R, Yang G, Li G. Jin R, et al. Neurobiol Dis. 2010 Jun;38(3):376-85. doi: 10.1016/j.nbd.2010.03.008. Epub 2010 Mar 17. Neurobiol Dis. 2010. PMID: 20302940 Free PMC article. Review.
Cited by
- Progress in the Treatment of Central Nervous System Diseases Based on Nanosized Traditional Chinese Medicine.
Li J, Long Q, Ding H, Wang Y, Luo D, Li Z, Zhang W. Li J, et al. Adv Sci (Weinh). 2024 Apr;11(16):e2308677. doi: 10.1002/advs.202308677. Epub 2024 Feb 28. Adv Sci (Weinh). 2024. PMID: 38419366 Free PMC article. Review. - Peptide-Based Agents for Cancer Treatment: Current Applications and Future Directions.
Nhàn NTT, Yamada T, Yamada KH. Nhàn NTT, et al. Int J Mol Sci. 2023 Aug 18;24(16):12931. doi: 10.3390/ijms241612931. Int J Mol Sci. 2023. PMID: 37629112 Free PMC article. Review. - D1 receptor-mediated endogenous tPA upregulation contributes to blood-brain barrier injury after acute ischaemic stroke.
Wang Y, Wang X, Zhang X, Chen S, Sun Y, Liu W, Jin X, Zheng G. Wang Y, et al. J Cell Mol Med. 2020 Aug;24(16):9255-9266. doi: 10.1111/jcmm.15570. Epub 2020 Jul 6. J Cell Mol Med. 2020. PMID: 32627929 Free PMC article. - Structural Biology and Protein Engineering of Thrombolytics.
Mican J, Toul M, Bednar D, Damborsky J. Mican J, et al. Comput Struct Biotechnol J. 2019 Jul 2;17:917-938. doi: 10.1016/j.csbj.2019.06.023. eCollection 2019. Comput Struct Biotechnol J. 2019. PMID: 31360331 Free PMC article. Review. - Canonical Wnt Pathway Maintains Blood-Brain Barrier Integrity upon Ischemic Stroke and Its Activation Ameliorates Tissue Plasminogen Activator Therapy.
Jean LeBlanc N, Menet R, Picard K, Parent G, Tremblay MÈ, ElAli A. Jean LeBlanc N, et al. Mol Neurobiol. 2019 Sep;56(9):6521-6538. doi: 10.1007/s12035-019-1539-9. Epub 2019 Mar 9. Mol Neurobiol. 2019. PMID: 30852795
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous